COVID-19 - August 17, 2020
AstraZeneca concludes agreement with the EC for the supply of COVID-19 vaccine
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. Building on the existing agreement with Europe’s Inclusive Vaccines Alliance spearheaded by Germany, France, Italy and the Netherlands, this new agreement will give all EU member states the option to access the vaccine […]
COVID-19 - August 17, 2020
Early data on Pfizer and BioNTech COVID-19 vaccine candidate
Pfizer and BioNTech have shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation. The newly released manuscript describes key safety and immunogenicity data from the U.S. Phase 1 trial for the BNT162b2 vaccine candidate, which at […]
COVID-19 - August 15, 2020
AstraZeneca initiates monoclonal antibody combination trial
The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention and treatment of COVID-19. The trial will evaluate the safety, tolerability and pharmacokinetics of AZD7442. It will include up to 48 healthy participants in the UK aged 18 to 55 […]
COVID-19 - August 14, 2020
New findings on the immune system’s role in severe COVID-19
By conducting advanced analyses of immune system activation in patients with severe COVID-19, researchers at Karolinska Institutet have managed to identify several cell types that play a key part in the immune response to the new coronavirus and the hyperinflammation seen in severe cases of the disease. The results are published in the scientific journal […]
COVID-19 - August 14, 2020
Danish project to identify the level of transmission of COVID-19
A new research project at the University of Copenhagen and Rigshospitalet will investigate the transmission of COVID-19 among people in the labour market in Denmark. The Novo Nordisk Foundation is awarding a grant of DKK 20 million to launch a new ambitious research project to identify the level of transmission of COVID-19 among people in the […]
COVID-19 - August 13, 2020
CEPI reserves manufacturing capacity for COVID-19 vaccines at SK bioscience
An agreement between CEPI and SK bioscience has secured capacity to manufacture COVID-19 vaccines at SK bioscience’s facilities in South Korea. The Coalition for Epidemic Preparedness Innovations’ (CEPI’s), headquarted in Oslo, Norway, mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during […]
